BWX Technologies, Inc. (BWXT)
NYSE: BWXT · IEX Real-Time Price · USD
99.14
+0.41 (0.42%)
Jul 26, 2024, 4:00 PM EDT - Market closed
BWX Technologies Revenue
BWX Technologies had revenue of $603.97M in the quarter ending March 31, 2024, with 6.26% growth. This brings the company's revenue in the last twelve months to $2.53B, up 11.52% year-over-year. In the year 2023, BWX Technologies had annual revenue of $2.50B with 11.80% growth.
Revenue (ttm)
$2.53B
Revenue Growth
+11.52%
P/S Ratio
3.60
Revenue / Employee
$324,604
Employees
7,800
Market Cap
9.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.50B | 263.48M | 11.80% |
Dec 31, 2022 | 2.23B | 108.76M | 5.12% |
Dec 31, 2021 | 2.12B | 558.00K | 0.03% |
Dec 31, 2020 | 2.12B | 228.60M | 12.06% |
Dec 31, 2019 | 1.89B | 95.03M | 5.28% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Aramark | 18.26B |
MasTec | 12.10B |
KBR, Inc. | 7.17B |
Generac Holdings | 4.02B |
Stantec | 3.83B |
Donaldson Company | 3.53B |
UL Solutions | 2.72B |
Crane Company | 2.14B |
BWXT News
- 4 days ago - BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production - Business Wire
- 23 days ago - Which Is A Better Defense Pick – Huntington Ingalls Stock Or BWX Technologies? - Forbes
- 4 weeks ago - BWX Technologies to Announce Second Quarter 2024 Results on Monday, August 5 - Business Wire
- 5 weeks ago - BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming - Business Wire
- 6 weeks ago - BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration's Pantex Plant - Business Wire
- 7 weeks ago - BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration - Business Wire
- 2 months ago - BWX Technologies Reports First Quarter 2024 Results - Business Wire
- 3 months ago - BWXT Named First Member of GE Vernova Nuclear's Small Modular Reactor Supplier Group - Business Wire